Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 15 Issue 2, June 2021

Volume 15 Issue 2

In this issue...

• Unraveling dealmaking in 2021

• New vaccine technologies take centre stage

• Central nervous system disorders: the top tens

• Exploring innovation in ophthalmic diseases

• Fast-tracking drug development with artificial intelligence

Syringe with vaccine and globe. Klaus Ohlenschlaeger / Alamy Stock Photo.

New vaccine approaches present new possibilities, but new challenges

High-value R&D partnerships of 2021


  • News Feature |

    Big pharma dealmaking returns to pre-pandemic levels as companies spend big to develop a range of cancer therapies.

    • Raveena Bhambra
  • Profiles

  • Advertisement Feature |

    Switzerland-based EsoCap has built a novel drug delivery system that aims to provide long-lasting local therapy in the upper gastrointestinal tract and is currently being tested in a phase 2 trial.

    • EsoCap AG
  • Advertisement Feature |

    Avalon GloboCare, a leading biotechnology company focusing on cell-based technology and therapeutics, is using its leading technology platforms to begin clinical trials of its potential COVID-19 therapy, a mucosal intranasal spray vaccination against SARS-CoV-2, and is developing drugs to combat cancer metastasis.

    • Avalon GloboCare Corp.
  • Advertisement Feature |

    A specialist in orally administered oncology agents, Taiho Oncology is expanding its portfolio through a growing internal pipeline of targeted therapies and a hunt to acquire new late-stage oncology assets.

    • Taiho Oncology

Evolution of the landscape for central nervous system disorder therapies

Partnering to improve vision

Tapping into the drug discovery potential of AI


Quick links